Arizona-based Critical Path Institute is pleased to announce it has been awarded a multi-year grant by the U.S. Food and Drug Administration to advance standards and methodologies designed to generate real-world evidence from real-world data through a neonatal pilot project through the International Neonatal Consortium.
↧